2026-2034年寵物長壽治療全球市場規模、佔有率、趨勢和成長分析報告

全球寵物長壽療法市場預計將從2025年的5.9023億美元成長至2034年的13.0862億美元，2026年至2034年的複合年成長率（CAGR）為9.25%。隨著寵物飼主越來越重視伴侶動物的長期健康和生活品質，該市場呈現強勁成長動能。人們對老齡化相關疾病的認知不斷提高、獸醫支出不斷增加以及與寵物之間情感紐帶的加深，都推動了對支持寵物健康老化的療法的需求。動物長壽研究的拓展也促進了該產業的發展。

生技公司正投資研發針對伴侶動物慢性疾病、細胞老化、免疫功能和代謝健康的創新療法。再生醫學、基因療法、營養科學和精準獸醫學的進步正在拓展治療的可能性。研究機構與獸醫服務提供者之間的合作正在加速先進長壽解決方案的商業化。

隨著對生物技術研究、個人化獸醫學和預防性醫療保健的持續投入，前景仍然十分光明。人工智慧驅動的藥物發現、生物標記開發和精準治療有望改善治療效果。全球寵物數量的不斷成長以及人們對高品質醫療保健解決方案日益成長的投入意願，將支撐該行業的長期持續發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球寵物長壽治療市場：依產品分類

• 市場分析、洞察與預測
• 補充
• 治療性食品

第5章：全球寵物長壽療法市場：以寵物類型分類

• 市場分析、洞察與預測
• 狗
• 貓
• 其他寵物

第6章：全球寵物長壽療法市場：依適應症分類

• 市場分析、洞察與預測
• 細胞能量和代謝韌性
• 認知老齡化與神經保護
• 維持肌肉骨骼系統的健康與活動能力
• 其他改編

第7章：全球寵物長壽治療市場：依通路分類

• 市場分析、洞察與預測
• 醫院和診所藥房
• 電子商務
• 實體店面
• 其他

第8章：全球寵物長壽治療市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Nestle SA
  • Royal Canin SAS
  • Hill's Pet Nutrition Inc
  • Nutramax Laboratories Veterinary Sciences Inc
  • Kormotech LLC
  • Zesty Paws
  • RENUE BY SCIENCE Inc
  • Quincy Bioscience, LLC
  • Antinol
  • Animal Essentials Inc
  • Vitality Science
  • Longevity For Animals
  • La Petite Labs
  • PETMADE

The global pet longevity therapeutics market size is expected to reach USD 1308.62 Million in 2034 from USD 590.23 Million in 2025, growing at a CAGR of 9.25 during 2026-2034.This market is gaining strong momentum as pet owners increasingly prioritize the long-term health and quality of life of companion animals. Growing awareness regarding age-related diseases, higher veterinary spending, and increasing emotional attachment to pets are driving demand for therapies that support healthy aging. Expanding research into animal longevity is also encouraging industry development.

Biotechnology companies are investing in innovative therapeutics targeting chronic diseases, cellular aging, immune function, and metabolic health in companion animals. Advances in regenerative medicine, gene therapy, nutritional science, and precision veterinary medicine are expanding treatment possibilities. Collaboration between research institutions and veterinary healthcare providers is accelerating the commercialization of advanced longevity solutions.

Future prospects remain highly promising with continued investment in biotechnology research, personalized veterinary care, and preventive health management. Artificial intelligence-assisted drug discovery, biomarker development, and precision therapeutics are expected to improve treatment effectiveness. Rising global pet ownership and increasing willingness to invest in premium healthcare solutions will support sustained long-term industry expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Supplements
• Therapeutic Food

By Pet

• Canine
• Feline
• Other Pets

By Indication

• Cellular Energy and Metabolic Resilience
• Cognitive Aging and Neuroprotection
• Musculoskeletal Integrity and Mobility Preservation
• Other Indications

By Distribution Channel

• Hospitals/Clinic Pharmacy
• E-commerce
• Offline Retail Stores
• Others

COMPANIES PROFILED

• Nestle S.A., Royal Canin SAS, Hill's Pet Nutrition Inc., Nutramax Laboratories Veterinary Sciences Inc., Kormotech LLC, Zesty Paws, RENUE BY SCIENCE Inc., Quincy Bioscience, LLC, Antinol, Animal Essentials Inc., Vitality Science, Longevity for Animals, La Petite Labs, PETMADE

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PET LONGEVITY THERAPEUTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutic Food Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PET LONGEVITY THERAPEUTICS MARKET: BY PET 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Pet
• 5.2. Canine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Feline Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Pets Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PET LONGEVITY THERAPEUTICS MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cellular Energy and Metabolic Resilience Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cognitive Aging and Neuroprotection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Musculoskeletal Integrity and Mobility Preservation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PET LONGEVITY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Hospitals/Clinic Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. E-commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Offline Retail Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PET LONGEVITY THERAPEUTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Pet
  • 8.2.3 By Indication
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Pet
  • 8.3.3 By Indication
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Pet
  • 8.4.3 By Indication
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Pet
  • 8.5.3 By Indication
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Pet
  • 8.6.3 By Indication
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PET LONGEVITY THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Nestle S.A
  • 10.2.2 Royal Canin SAS
  • 10.2.3 Hill's Pet Nutrition Inc
  • 10.2.4 Nutramax Laboratories Veterinary Sciences Inc
  • 10.2.5 Kormotech LLC
  • 10.2.6 Zesty Paws
  • 10.2.7 RENUE BY SCIENCE Inc
  • 10.2.8 Quincy Bioscience, LLC
  • 10.2.9 Antinol
  • 10.2.10 Animal Essentials Inc
  • 10.2.11 Vitality Science
  • 10.2.12 Longevity For Animals
  • 10.2.13 La Petite Labs
  • 10.2.14 PETMADE